Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

Rhea-AI Summary

Venus Concept (NASDAQ: VERO) announced its financial results for Q1 fiscal year 2021 will be released on May 17, 2021, after market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss these results, with participation details provided for both domestic and international callers. The call will also be available via a live webcast and archived for later access. Venus Concept is known for its innovative medical aesthetic technologies, operating in over 60 countries with a subscription-based sales model.

Positive

• Strong global presence in over 60 countries.
• Diverse product portfolio focusing on minimally invasive and non-invasive technologies.
• Robust support from leading healthcare growth equity investors.

Negative

• None.

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17, 2021.

Management will host a conference call at 5:00 p.m. Eastern Time on May 17, 2021 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13718675. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13718675. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 20 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

FAQ

When will Venus Concept release its Q1 fiscal year 2021 financial results?

Venus Concept will release its Q1 fiscal year 2021 financial results on May 17, 2021, after market close.

What time is the conference call for Venus Concept's Q1 financial results?

The conference call is scheduled for May 17, 2021, at 5:00 PM Eastern Time.

How can I participate in the Venus Concept conference call?

To participate in the conference call, dial 877-407-2991 (or 201-389-0925 for international callers) and use access code 13718675.

Where can I find the webcast of the Venus Concept conference call?

The live webcast will be available on the investor relations section of the Venus Concept website.

Is there a replay available for the Venus Concept conference call?

Yes, a replay of the call will be available for two weeks at 877-660-6853 (or 201-612-7415 for international callers) with access code 13718675.